1. A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis. Issue 1 (January 1991) Authors: Jayson, M I; Holland, C D; Keegan, A; Illingworth, K; Taylor, L Journal: Annals of the rheumatic diseases Issue: Volume 50:Issue 1(1991) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-254 Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS): impact on endometrium and genital tract microbiota. (30th June 2022) Authors: Mackens, S; Olsen, C; Centelles-Lodeiro, J; Illingworth, K; Brucker, M. De; Boudry, L; Tournaye, H; Raes, J; Vieira-Silva, S; Blockeel, C Journal: Human reproduction Issue: Volume 37(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P–619 Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: a double blind, cross-over, pharmacokinetic study. (6th August 2021) Authors: Mackens, S; Brucker, M D; Illingworth, K; Tournaye, H; Blockeel, C Journal: Human reproduction Issue: Volume 36:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Issue 2 (February 1996) Authors: Herrick, A L; Illingworth, K; Blann, A; Hay, C R; Hollis, S; Jayson, M I Journal: Annals of the rheumatic diseases Issue: Volume 55:Issue 2(1996) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗